| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.856 | 6.012 | 8.308 | 9.025 | 8.851 | 6.843 | 7.783 | 7.807 | 7.905 | 9.469 |
| Total Income - EUR | 3.856 | 6.012 | 8.308 | 9.025 | 8.851 | 7.417 | 7.783 | 7.807 | 7.905 | 9.469 |
| Total Expenses - EUR | 3.535 | 4.019 | 4.754 | 5.139 | 5.505 | 4.869 | 5.827 | 6.465 | 7.738 | 8.909 |
| Gross Profit/Loss - EUR | 321 | 1.993 | 3.554 | 3.886 | 3.346 | 2.548 | 1.956 | 1.342 | 166 | 559 |
| Net Profit/Loss - EUR | 205 | 1.873 | 3.471 | 3.796 | 3.257 | 2.474 | 1.878 | 1.264 | 87 | 275 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medicina Alternativa Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 765 | 2.706 | 6.161 | 9.882 | 12.987 | 10.907 | 8.310 | 5.606 | 2.102 | 1.262 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 45 | 42 | 49 | 49 | 49 |
| Cash | 765 | 2.706 | 6.161 | 9.882 | 12.987 | 10.861 | 8.268 | 5.557 | 2.053 | 1.213 |
| Shareholders Funds | 452 | 2.321 | 5.752 | 9.442 | 12.517 | 10.412 | 7.814 | 4.843 | 1.398 | 323 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 313 | 386 | 409 | 440 | 470 | 495 | 497 | 763 | 704 | 939 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Medicina Alternativa Srl